Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Outset Medical, Inc.OM · Entity 7026 | Chief Operating Officer | March 01, 2023 | March 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Outset Medical, Inc.
Report date March 01, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,112 |
Reported balance
After 2023-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-03-01 · Exercise / conversion · Acquired 5,000 · Balance 108,112 |
| Common StockSEC Table I · non-derivative | Direct | 103,112 |
Reported balance
After 2023-03-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-03-01 · Sale · Disposed 5,000 · Balance 103,112 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. F3: Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c). |
| Performance Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.88 · Expires 2027-12-19 | Direct | 43,507 |
Reported balance
After 2023-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-01 · Exercise / conversion · Disposed 5,000 · Balance 43,507 F4: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F2: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.
F3: Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).
F4: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $48.70 | $243,518.50 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.77 to $49.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,000 | $48.70 | $292,187.40 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.77 to $49.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,000 | $3.88 | $23,280.00 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 16:40 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000062 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,989 Underlying: Common Stock · 6,500 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 16:40 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,500 | $55.00 | $357,500.00 |
DisclosureSEC source: 0001484612-21-000062 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 16:40 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,500 | $3.88 | $25,220.00 |
DisclosureSEC source: 0001484612-21-000062 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 16:38 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000061 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,989 Underlying: Common Stock · 6,500 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 16:38 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,500 | $55.00 | $357,500.00 |
DisclosureSEC source: 0001484612-21-000061 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 16:38 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,500 | $3.88 | $25,220.00 |
DisclosureSEC source: 0001484612-21-000061 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 19:51 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000057 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,489 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 19:51 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $49.17 | $245,852.50 |
DisclosureSEC source: 0001484612-21-000057 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.62 to $49.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 19:51 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000057 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Dec 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000086 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,489 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 01, 2021 Filed Dec 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $49.17 | $245,852.50 |
DisclosureSEC source: 0001484612-21-000086 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.62 to $49.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document |
| September 01, 2021 Filed Dec 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000086 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 17:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000048 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,489 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 17:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $40.71 | $203,546.00 |
DisclosureSEC source: 0001484612-21-000048 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $40.03 to $41.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 17:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000048 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · derivative · entry 9 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,489 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · derivative · entry 8 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,489 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · derivative · entry 7 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,489 Underlying: Common Stock · 6,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $49.24 | $246,207.50 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · nonDerivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14. 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.65 to $50.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · nonDerivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $49.26 | $246,279.00 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14. 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.65 to $50.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,000 | $49.24 | $295,436.40 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14. 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.65 to $50.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 16:37 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,000 | $3.88 | $23,280.00 |
DisclosureSEC source: 0001484612-21-000041 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 17:28 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000012 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,489 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting period. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 17:28 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $47.91 | $239,529.00 |
DisclosureSEC source: 0001484612-21-000012 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14. 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.45 to $48.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 17:28 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000012 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,068 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0000905148-21-000431 · form4.xml · derivative · entry 7 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,489 Underlying: Common Stock · 2,068 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting period. Read SEC document |
| May 03, 2021 Filed May 5, 2021 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Stock Option (Right to Buy) · Derivative | 2,932 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0000905148-21-000431 · form4.xml · derivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,932 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 237 | $59.81 | $14,174.00 |
DisclosureSEC source: 0000905148-21-000431 · form4.xml · nonDerivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $59.77 to $60.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). Read SEC document |
| May 03, 2021 Filed May 5, 2021 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 539 | $58.82 | $31,706.24 |
DisclosureSEC source: 0000905148-21-000431 · form4.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,492 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $58.48 to $58.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| May 03, 2021 Filed May 5, 2021 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 4,224 | $57.89 | $244,525.67 |
DisclosureSEC source: 0000905148-21-000431 · form4.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,031 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $57.46 to $58.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). Read SEC document |
| May 03, 2021 Filed May 5, 2021 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 2,068 | $3.88 | $8,023.84 |
DisclosureSEC source: 0000905148-21-000431 · form4.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 18:18 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 2,932 | $3.88 | $11,376.16 |
DisclosureSEC source: 0000905148-21-000431 · form4.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 09:17 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Stock Option (Right to Buy) · Derivative | 9,784 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001140361-21-011513 · form4.xml · derivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,932 Underlying: Common Stock · 9,784 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This Form 4 corrects the exercise price previously reported as $3.87 on the Form 3 filed on September 14, 2020. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 09:17 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Stock Option (Right to Buy) · Derivative | 12,716 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001140361-21-011513 · form4.xml · derivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,716 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This Form 4 corrects the exercise price previously reported as $3.87 on the Form 3 filed on September 14, 2020. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 09:17 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,503 | $55.36 | $138,572.34 |
DisclosureSEC source: 0001140361-21-011513 · form4.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $55.23 to $55.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 09:17 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 19,997 | $55.01 | $1,100,094.96 |
DisclosureSEC source: 0001140361-21-011513 · form4.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,758 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020. F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $54.23 to $55.222, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 09:17 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 9,784 | $3.88 | $37,961.92 |
DisclosureSEC source: 0001140361-21-011513 · form4.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 09:17 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 12,716 | $3.88 | $49,338.08 |
DisclosureSEC source: 0001140361-21-011513 · form4.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:09 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantStock Option (Right to Buy) · Derivative | 16,416 | $0.00 Strike: $25.89 | $0.00 |
DisclosureSEC source: 0001140361-21-008970 · form4.xml · derivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,416 Underlying: Common Stock · 16,416 shares Expires 2031-03-14 F2 · derivative.exercise_date: This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:09 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 8,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-008970 · form4.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on March 15, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 25% on March 15, 2022, then quarterly over three years on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 15:02 UTC Amendment | Outset Medical, Inc. OM · Entity 7026 | GrantStock Option (Right to Buy) · Derivative | 16,416 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001140361-21-009047 · form4.xml · derivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,416 Underlying: Common Stock · 16,416 shares Expires 2031-03-14 F2 · derivative.exercise_price: This Form 4 amendment is being filed to correct the exercise price. F1 · derivative.exercise_date: This option vests 25% on March 15, 2022, and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| September 17, 2020 Filed Sep 17, 2020 20:24 UTC | Outset Medical, Inc. OM · Entity 7026 | PurchaseCommon Stock | 1,000 | $27.00 | $27,000.00 |
DisclosureSEC source: 0001140361-20-020796 · form4.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.